Page 1 of 4 No. RJH – SET 3/2018 26 February 2018 Subject : Management’s Discussion and Analysis for the fourth Quarter of 2017 and year ended December 31, 2017 To : The President The Stock Exchange
ที่ FPI Ref. FPI.024/2018 12 November 2018 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2018 To : Board of Directors and President of The Stock Exchange of Thailand
November 13, 2018 Subject: MD&A for the financial statements of the 3rd quarter of fiscal year 2018 ended as of September 30, 2018 To: The President The Stock Exchange of Thailand Aapico Hitech Public
19 เมษายน 2539 1 (TRANSLATION) Tor. For. 6 / 2020 May 14, 2020 Subject: (1) Submission of the Financial Statements for Q1/2020 (2) The resolution to appoint the Company’s auditor (3) Management
1 No. CC20171103ELE November 13, 2017 Subject Report of the Resolutions of Board of Directors’ Meeting No. 5/2017 To President The Stock Exchange of Thailand The Board of Directors’ meeting of Cal
(THIS REPORT DISCUSSES PRINCIPAL CHANGES ON THE UNREVIEWED CONSOLIDATED FINANCIAL STATEMENT) LH FINANCIAL GROUP PUBLIC COMPANY LIMITED MANAGEMENT DISCUSSION AND ANALYSIS FOR THE FIRST QUARTER ENDED
(THIS REPORT DISCUSSES PRINCIPAL CHANGES ON THE REVIEWED CONSOLIDATED FINANCIAL STATEMENT) LH FINANCIAL GROUP PUBLIC COMPANY LIMITED MANAGEMENT DISCUSSION AND ANALYSIS FOR THE FIRST QUARTER ENDED 31
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like